These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

192 related articles for article (PubMed ID: 36994064)

  • 61. Increased incidence of rhino-orbital mucormycosis in an educational therapeutic hospital during the COVID-19 pandemic in western Iran: An observational study.
    Avatef Fazeli M; Rezaei L; Javadirad E; Iranfar K; Khosravi A; Amini Saman J; Poursabbagh P; Ghadami MR; Parandin MM; Dehghani A; Ahmadi Jouybari T; Mahdavian B; Eivazi N; Rezaei S; Rezaei A; Emami B; Haqgou M; Bozorgomid A; Sayad B
    Mycoses; 2021 Nov; 64(11):1366-1377. PubMed ID: 34252988
    [TBL] [Abstract][Full Text] [Related]  

  • 62. COVID-19 associated Mucormycosis (CAM): Implications for perioperative physicians - A narrative review.
    Gupta A; Kayarat B; Gupta N
    Saudi J Anaesth; 2023; 17(1):58-64. PubMed ID: 37032681
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Oral Tissue Involvement and Probable Factors in Post-COVID-19 Mucormycosis Patients: A Cross-Sectional Study.
    Chandwani N; Dabhekar S; Selvi K; Mohamed RN; Abullais SS; Moothedath M; Jadhav G; Chandwani J; Karobari MI; Pawar AM
    Healthcare (Basel); 2022 May; 10(5):. PubMed ID: 35628049
    [TBL] [Abstract][Full Text] [Related]  

  • 64. A Proposed Grading System and Experience of COVID-19 Associated Rhino Orbito Cerebral Mucormycosis from an Indian Tertiary Care Center.
    Vaid N; Mishra P; Gokhale N; Vaid S; Vaze V; Kothadiya A; Deka T; Agarwal R
    Indian J Otolaryngol Head Neck Surg; 2022 Oct; 74(Suppl 2):3505-3512. PubMed ID: 34804905
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Rhino-orbito-cerebral mucormycosis in a post-COVID-19 diabetic patient: Rare case from Iran.
    Fakhar M; Sharifpour A; Zakariaei Z; Banimostafavi ES; Soleymani M; Davoodi L
    Clin Case Rep; 2022 Feb; 10(2):e05506. PubMed ID: 35237439
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Clinical Features and Mortality of COVID-19-Associated Mucormycosis: A Systematic Review and Meta-Analysis.
    Watanabe A; So M; Mitaka H; Ishisaka Y; Takagi H; Inokuchi R; Iwagami M; Kuno T
    Mycopathologia; 2022 Jun; 187(2-3):271-289. PubMed ID: 35312945
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Rhino-orbital-cerebral mucormycosis in times of COVID-19: A neurosurgical experience.
    Singh H; Dua S; Goel A; Dhar A; Bhadauria V; Garg A; Katyar V; Sharma S; Shukla A
    Surg Neurol Int; 2021; 12():538. PubMed ID: 34754588
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Rhino-orbital-cerebral mucormycosis: An epidemiological study from a tertiary care referral center in Western India.
    Patel R; Jethva J; Bhagat PR; Prajapati V; Thakkar H; Prajapati K
    Indian J Ophthalmol; 2022 Apr; 70(4):1371-1375. PubMed ID: 35326057
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Hyperglycemia and steroid use increase the risk of rhino-orbito-cerebral mucormycosis regardless of COVID-19 hospitalization: Case-control study, India.
    Ponnaiah M; Ganesan S; Bhatnagar T; Thulasingam M; Majella MG; Karuppiah M; Rizwan SA; Alexander A; Sarkar S; Kar SS; Kadhiravan T; Bhatnagar A; S PK; Pillai VM; Nair PP; Dhodapkar R; Ch Toi P; Singh R; Kasthuri N; Kumar GCP; Jaisankar S; Saini V; Kankaria A; Raj A; Goyal A; Sharma V; Khichar S; Soni K; Garg MK; Selvaraj K; B H S; Bhavana K; Bharti B; Singh CM; Chaudhary N; R V; K G; Palaninathan K; Dube S; Saxena RS; Gupta N; Rathinavel A; Priya S; Arulsundareshkumar ; Bellad SA; Kavi A; Harugop AS; Pujary K; Ballala K; Mallya SD; Prasad HM; Ravi D; Balaji NK; Hegde R; Mishra N; Ray S; Karthikeyan S; Ramalingam S; Murali A; Vaidya S; Samadhiya M; Bhojani D; Lakshmanan S; Singh SRB; Pillai N; Deepthi P; Banumathi K; Sumathi V; Ramesh D; Nissar SP; Sheikh KM; Patel MN; Shristava V; Kumar SS; Shantaraman K; Pandian RD; Murhekar M; Aggarwal R
    PLoS One; 2022; 17(8):e0272042. PubMed ID: 35939442
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Rhino-orbital mucormycosis: Our experiences with clinical features and management in a tertiary care center.
    Singh SP; Rana J; Singh VK; Singh R; Sachan R; Singh S; Jain S
    Rom J Ophthalmol; 2021; 65(4):339-353. PubMed ID: 35087975
    [No Abstract]   [Full Text] [Related]  

  • 71. Spectrum of intracranial complications of rhino-orbito-cerebral mucormycosis - resurgence in the era of COVID-19 pandemic: a pictorial essay.
    Kaushik KS; Ananthasivan R; Acharya UV; Rawat S; Patil UD; Shankar B; Jose A
    Emerg Radiol; 2021 Dec; 28(6):1097-1106. PubMed ID: 34605991
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Spike in Rhino-Orbital-Cerebral Mucormycosis Cases Presenting to a Tertiary Care Center During the COVID-19 Pandemic.
    Fouad YA; Abdelaziz TT; Askoura A; Saleh MI; Mahmoud MS; Ashour DM; Ashour MM
    Front Med (Lausanne); 2021; 8():645270. PubMed ID: 34124087
    [No Abstract]   [Full Text] [Related]  

  • 73. A Retrospective Study to Evaluate the Perioperative Clinical Characteristics and Outcomes of Rhino-Orbital Cerebral Mucormycosis in COVID-19 Patients at a Tertiary Care Hospital in India.
    Kumari R; Talawar P; Tripaty DK; Singla D; Kaushal A; Sharma S; Malhotra M; Boruah P; Sangadala P; Kumar KS
    Cureus; 2023 Jul; 15(7):e41613. PubMed ID: 37565105
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Frequency and survival of Covid associated mucormycosis patients at tertiary care hospitals in Pakistan: A retrospective observational study.
    Irfan A; Kamran AH; Ammar M; Rahman SU
    Health Sci Rep; 2023 Feb; 6(2):e1083. PubMed ID: 36761033
    [TBL] [Abstract][Full Text] [Related]  

  • 75. COVID-19 associated rhino-orbital-cerebral mucormycosis: An observational study from Eastern India, with special emphasis on neurological spectrum.
    Dubey S; Mukherjee D; Sarkar P; Mukhopadhyay P; Barman D; Bandopadhyay M; Pandit A; Sengupta A; Das S; Ghosh S; Adhikari S; Biswas PS; Pal P; Roy H; Patra N; Das A; Sinha P; Mondal MK; Shrivastava SR; Bhattacharya K; Mukhopadhyay M; Ahmed K; Halder TK; Saha M; Ahmed K; Maity S; Mandal A; Chatterjee D; Saha S; Chunakar A; Saha A; Ray BK
    Diabetes Metab Syndr; 2021; 15(5):102267. PubMed ID: 34509790
    [TBL] [Abstract][Full Text] [Related]  

  • 76. "MuCovid-21" study: Mucormycosis at an Indian tertiary care centre during the COVID-19 pandemic.
    Kumar S; Choudhary R; Pandey VP
    J R Coll Physicians Edinb; 2021 Dec; 51(4):352-358. PubMed ID: 34882132
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Study of Profile of Mucormycosis During the Second Wave of COVID-19 in a Tertiary Care Hospital.
    Kamath S; Kumar M; Sarkar N; Ahmed T; Sunder A
    Cureus; 2022 Jan; 14(1):e21054. PubMed ID: 35155019
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Rhino-orbital mucormycosis following COVID-19 in previously non-diabetic, immunocompetent patients.
    Nair AG; Adulkar NG; D'Cunha L; Rao PR; Bradoo RA; Bapaye MM; Kothari A; Dave TV; Shinde CA
    Orbit; 2021 Dec; 40(6):499-504. PubMed ID: 34338124
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Post-Covid-19 Rhino-Cerebral Mucormycosis: an Observational Study During the Second Wave.
    Sajjan A; Nimbal AV; Shahapur R; Bagoji IB; Chiniwar VA; Chillalashetti SK
    Maedica (Bucur); 2022 Mar; 17(1):103-106. PubMed ID: 35733739
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Tracing, Tracking and Treating COVID-19 Associated Rhino-Orbito Cerebral Mucormycosis (ROCM).
    Bidkar V; Shrikrishna BH; Dabhekar S; Prathipati KK; Joshi PP; Gadkari R; Mishra M; Selvaraj K; Ratnaparakhi C; Prakash A; Pattebahadur R; Chellapan A; Shanbag R
    Indian J Otolaryngol Head Neck Surg; 2022 Oct; 74(Suppl 2):3304-3312. PubMed ID: 35999950
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.